Posted 19th March 2018 by Kate Barlow
Following on from his previous article about his research into the effects of everyday cosmetics on the skin microbiome, Kit Wallen-Russell delves deeper into the issues of the skin microbiome, by comparing the differences between biodiverse skin care and probiotic skin care.
Posted 27th December 2017 by Laura Berry
Defined health outcomes are increasingly being linked to prebiotic ingredients and supplements. For example, mounting evidence recently led the FDA to issue a qualified health claim regarding the ability of digestion resistant starch to reduce the risk of type 2 diabetes. With the direct annual cost of diabetes recently estimated to be $825B (1), the potential application of prebiotics to reduce disease risk is appealing from both health care and business investment perspectives.
Posted 18th December 2017 by Laura Berry
2017 has been another big year for microbiome research. Not only is funding at an all-time high but the shift from 16S to whole-genome sequencing means that we are able to deduce the role it plays in health more effectively.
Posted 13th December 2017 by Laura Berry
A prebiotic is defined as “a substrate that is selectively utilised by host microorganisms conferring a health benefit”. This updated consensus definition from the International Scientific Association for Probiotics and Prebiotics expands the application outside the digestive tract.
Posted 4th October 2017 by Laura Berry
Interest in microbiota has reached all areas of human health and disease. As a result, the therapeutic potential of probiotics has expanded. 2013 saw a surge of investment into prebiotics and probiotics, coinciding with an increase in microbiome funding. In the last decade, investment has quadrupled.
Posted 25th September 2017 by Laura Berry
Colorectal cancer (CRC) is the result of a series of histopathological changes starting with the appearance of outbreaks of aberrant crypts (AC) in the colon and generally leading to adenocarcinoma. CRC is one of the third most common diagnosed cancers in western countries.
Posted 28th August 2017 by Laura Berry
Image credit: NIAID, Flickr, licensed under CC BY 2.0
Autoimmune diseases are an outcome of a dysfunctional immune system. Most common autoimmune diseases, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), are polygenic autoimmune disorders. However, several monogenic autoimmune disorders have been identified.